This is very new and exciting. Just a case history for now, but apparently they have done a Left Atrial Appendage (LAA)Closure during an RF catheter ablation procedure, guided by 3D printing technology!
As many of you know, there now exist several devices like Watchman and Amulet that are inserted into the left atrial appendage via catheter, sometimes as a standalone procedure, but usually as part of an afib catheter ablation. Studies show that patients with these types of devices are at the same reduced stroke risk as those on daily anti-coagulants (AC's). However, the issue with these devices, even though you can stop AC's, are that you still have to remain on low dose daily aspirin for life, which some may not want for various reasons.
The alternative has been a true LAA closure procedure like AtriClip. Like it's name suggests, there the LAA is simply clipped off. The results are as good, if not better than Watchman, but daily aspirin is not required for life. The downside, however, is that unless you are combining this with a mini maze procedure where AtriClip or similar are routinely used, AtriClip is much more invasive than Watchman/Amulet.
So, it sounds like if this case study ever comes to fruition, we may have the best of both worlds. A relatively non invasive procedure to clip off the LAA, giving us the same stroke prevention as AC's without their risks and without the risks of daily aspirin.* A procedure that could be done at the same time as catheter ablation, but I also see it as a standalone for those who have already been ablated, or do not require ablation.
There is the issue that strokes can originate from other than the LAA, but again, there is strong study data to show that an LAA closure device in the real world prevents strokes just as well as daily AC's, with less bleed risk.
Anyway, I'm excited and am going now going to right now check out 3D printer prices on Amazon
Link to article below.
Jim
* I'm assuming daily aspirin is not required, however do not have access to the full-text version, nor is this procedure at the trial stage yet.